Evidence map›Paper›PMID 34281623›Full record

ReviewAntimicrobial resistance and infection control2021

Reducing the risk of tuberculosis transmission for HCWs in high incidence settings.

Ana Paleckyte, Oshani Dissanayake, Stella Mpagama, Marc C Lipman, Timothy D McHugh

Abstract readReview
In one paragraph

Review in Antimicrobial resistance and infection control, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Structural guidelines for the sustainability of the tuberculosis infection control planBiomedica : revista del Instituto Nacional de Salud · 2026
    Article
  4. Observational
  5. Methicillin-ResistantMicroorganisms · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Tuberculosis infection control in MDR-TB designated hospitals in Jiangsu Province, China.Journal of clinical tuberculosis and other mycobacterial diseases · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ana PaleckyteUCL Centre for Clinical Microbiology, Division of Infection & Immunity, UCL, London, UK.
Oshani DissanayakeInfectious Diseases, Royal Free London NHS Foundation Trust, London, UK.
Stella MpagamaKibong'oto Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Marc C LipmanUCL Respiratory, Division of Medicine, UCL, London, UK.
Timothy D McHughUCL Centre for Clinical Microbiology, Division of Infection & Immunity, UCL, London, UK. t.mchugh@ucl.ac.uk.ORCID 0000-0003-4658-8594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Globally, tuberculosis (TB) is a leading cause of death from a single infectious agent. Healthcare workers (HCWs) are at increased risk of hospital-acquired TB infection due to persistent exposure to Mycobacterium tuberculosis (Mtb) in healthcare settings. The World Health Organization (WHO) has developed an international system of infection prevention and control (IPC) interventions to interrupt the cycle of nosocomial TB transmission. The guidelines on TB IPC have proposed a comprehensive hierarchy of three core practices, comprising: administrative controls, environmental controls, and personal respiratory protection. However, the implementation of most recommendations goes beyond minimal physical and organisational requirements and thus cannot be appropriately introduced in resource-constrained settings and areas of high TB incidence. In many low- and middle-income countries (LMICs) the lack of knowledge, expertise and practice on TB IPC is a major barrier to the implementation of essential interventions. HCWs often underestimate the risk of airborne Mtb dissemination during tidal breathing. The lack of required expertise and funding to design, install and maintain the environmental control systems can lead to inadequate dilution of infectious particles in the air, and in turn, increase the risk of TB dissemination. Insufficient supply of particulate respirators and lack of direction on the re-use of respiratory protection is associated with unsafe working practices and increased risk of TB transmission between patients and HCWs. Delayed diagnosis and initiation of treatment are commonly influenced by the effectiveness of healthcare systems to identify TB patients, and the availability of rapid molecular diagnostic tools. Failure to recognise resistance to first-line drugs contributes to the emergence of drug-resistant Mtb strains, including multidrug-resistant and extensively drug-resistant Mtb. Future guideline development must consider the social, economic, cultural and climatic conditions to ensure that recommended control measures can be implemented in not only high-income countries, but more importantly low-income, high TB burden settings. Urgent action and more ambitious investments are needed at both regional and national levels to get back on track to reach the global TB targets, especially in the context of the COVID-19 pandemic.

Indexed as

Health PersonnelCOVID-19HumansIatrogenic DiseaseIncidenceInfectious Disease Transmission, Patient-to-ProfessionalRisk FactorsTuberculosisHealthcare workersLMICMDR-TBTransmissionTuberculosis

Identifiers

PMID34281623
PMCPMC8287104

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.